PDE10A anticorps (C-Term)
Aperçu rapide pour PDE10A anticorps (C-Term) (ABIN7464812)
Antigène
Voir toutes PDE10A AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Humain, Souris, Rat
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein encompassing a sequence within the C-terminus region of human PDE10A. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:500-1:20000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Commentaires
-
Positive Control: Myc-DDK-tagged PDE10A-transfected 293T
Validation: Comparison, Overexpression
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.97 mg/mL
-
Buffer
- 1XPBS pH 7, 20 % Glycerol, 0.025 % ProClin 300
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- PDE10A (phosphodiesterase 10A (PDE10A))
-
Autre désignation
- phosphodiesterase 10A
-
Sujet
- Phosphodiesterase 10A , ADSD2 , HSPDE10A , IOLOD , LINC00473 , PDE10A19,Various cellular responses are regulated by the second messengers cAMP and cGMP. Phosphodiesterases, such as PDE10A, eliminate cAMP- and cGMP-mediated intracellular signaling by hydrolyzing the cyclic nucleotide to the corresponding nucleoside 5-prime monophosphate (Fujishige et al., 2000 [PubMed 10998054]).[supplied by OMIM]
-
Poids moléculaire
- 88 kDa
-
ID gène
- 10846
-
UniProt
- Q9Y233
-
Pathways
- cAMP Metabolic Process
Antigène
-